Bright Minds BiosciencesDRUG 
$1.294.03%24h
4.03%24h
Global rank34200
Market cap$4.80M
Change 7d4.45%
YTD Performance-13.42%
SP500 benchmarkUnderperform
P/E-0.65
P/S0
Revenue$0
Earnings-$5.42M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Bright Minds Biosciences (DRUG)
Bright Minds Biosciences has an EPS of $-1.98. In 2022, the company made an earnings per share (EPS) of $-6.06. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for DRUG
-
Value:-
EPS history for Bright Minds Biosciences from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$1.98 | -67.33% |
| 2022 | -$6.06 | 25.73% |
| 2021 | -$4.82 | 1185.02% |
| 2020 | -$0.375091 | - |
View the highest EPS stocks
